Vital Pursuit will include whole-grain bowls, protein pasta, sandwich melts and gluten-free options.
Nestle is launching a new line of high-fiber, protein-packed foods directed at the growing number of Americans on Wegovy or Ozempic , and others trying to lose weight. Called Vital Pursuit foods, the products are 'well-suited to support a balanced diet for anyone on a weight management journey' the Swiss food and beverage maker said Tuesday, but 'are portion-aligned' for consumers taking GLP-1 medications, also known as semaglutides.
'We know that every consumer on a health journey has individualized needs and considerations, and having options to support those needs will continue to play an important role,' Tom Moe, president of Nestle USA Meals Division, said in a statement. Nestle's move comes as GLP-1 medications are becoming more widely used for weight management and other newly discovered potential health benefits.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Nestle Set to Sell $5 Pizza, Sandwiches for Wegovy, Ozempic UsersNestle will market a new, $5 line of frozen pizzas and protein-enriched pastas in the United States which it says it designed specifically for people taking drugs such as...
Read more »
Wegovy users keep weight off for 4 years: How Wegovy helps the heartPatients taking Novo Nordisk’s Wegovy obesity treatment maintained an average of 10% weight loss after four years, potentially boosting the drugmaker’s case to insurers and governments to cover the cost of the effective but expensive drug.
Read more »
Sanders Launches Probe of 'Outrageously Overpriced' Ozempic and WegovyBrett Wilkins is a staff writer for Common Dreams.
Read more »
Novo Nordisk announces $6B investment in Ozempic, Wegovy amid shortagesNovo Nordisk's Negelle Morris spoke exclusively with ABC News.
Read more »
Novo Nordisk To Slash Prices On Buzzy Drugs Ozempic and WegovyScience and Technology News and Videos
Read more »
US Senate committee investigates pricing of Novo's Ozempic and WegovyUS Senate committee investigates pricing of Novo's Ozempic and Wegovy
Read more »